Increased Functional Connectivity Between Brain Regions Involved in Social Cognition, Emotion and Affective-value in Psychedelic States Induced by N,N-Dimethyltryptamine (DMT)

Overview

Journal Front Pharmacol

Date 2024 Nov 14

PMID 39539622

Authors

Carla Soares

Gisela Lima

Marta Lapo Pais

Marta Teixeira

Celia Cabral

Miguel Castelo-Branco

Affiliations

Soon will be listed here.

Abstract

The modulation of social cognition is suggested as a possible mechanism contributing to the potential clinical efficacy of psychedelics in disorders involving socio-emotional and reward processing deficits. Resting-state functional Magnetic Resonance Imaging (rs-fMRI) can be used to detect changes in brain connectivity during psychedelic-induced states. Thus, this pharmacoimaging study investigates the effects of N,N-Dimethyltryptamine (DMT) on functional connectivity in brain areas relevant to social cognition, using a within-subject design in eleven healthy experienced users. The study included both an active and a control condition, conducted at different time points. The active condition involved DMT inhalation, while the control condition did not. Seed-based connectivity was measured for the two core regions involved in theory of mind and emotional processing, respectively, the posterior supramarginal gyrus and the amygdala. DMT increased supramarginal gyrus connectivity with the precuneus, posterior cingulate gyrus, amygdala, and orbitofrontal cortex. Additionally, increased connectivity emerged between the amygdala and orbitofrontal cortex. These results demonstrate that DMT modulates brain connectivity in socio-emotional and affective-value circuits, advancing our understanding of the neural mechanisms underlying the psychedelic experience and its potential therapeutic action.

References

Riva F, Lenger M, Kronbichler M, Lamm C, Silani G . The role of right supra-marginal gyrus and secondary somatosensory cortex in age-related differences in human emotional egocentricity. Neurobiol Aging. 2022; 112:102-110. DOI: 10.1016/j.neurobiolaging.2022.01.002. View

Andersson J, Hutton C, Ashburner J, Turner R, Friston K . Modeling geometric deformations in EPI time series. Neuroimage. 2001; 13(5):903-19. DOI: 10.1006/nimg.2001.0746. View

Palhano-Fontes F, Barreto D, Onias H, Andrade K, Novaes M, Pessoa J . Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial. Psychol Med. 2018; 49(4):655-663. PMC: 6378413. DOI: 10.1017/S0033291718001356. View

Weightman M, Air T, Baune B . A review of the role of social cognition in major depressive disorder. Front Psychiatry. 2015; 5:179. PMC: 4263091. DOI: 10.3389/fpsyt.2014.00179. View

Carbonaro T, Gatch M . Neuropharmacology of N,N-dimethyltryptamine. Brain Res Bull. 2016; 126(Pt 1):74-88. PMC: 5048497. DOI: 10.1016/j.brainresbull.2016.04.016. View

Preller K, Schilbach L, Pokorny T, Flemming J, Seifritz E, Vollenweider F . Role of the 5-HT Receptor in Self- and Other-Initiated Social Interaction in Lysergic Acid Diethylamide-Induced States: A Pharmacological fMRI Study. J Neurosci. 2018; 38(14):3603-3611. PMC: 6596041. DOI: 10.1523/JNEUROSCI.1939-17.2018. View

Kraehenmann R, Preller K, Scheidegger M, Pokorny T, Bosch O, Seifritz E . Psilocybin-Induced Decrease in Amygdala Reactivity Correlates with Enhanced Positive Mood in Healthy Volunteers. Biol Psychiatry. 2014; 78(8):572-81. DOI: 10.1016/j.biopsych.2014.04.010. View

Good M, Joel Z, Benway T, Routledge C, Timmermann C, Erritzoe D . Pharmacokinetics of N,N-dimethyltryptamine in Humans. Eur J Drug Metab Pharmacokinet. 2023; 48(3):311-327. PMC: 10122081. DOI: 10.1007/s13318-023-00822-y. View

Corradi-DellAcqua C, Hofstetter C, Vuilleumier P . Cognitive and affective theory of mind share the same local patterns of activity in posterior temporal but not medial prefrontal cortex. Soc Cogn Affect Neurosci. 2013; 9(8):1175-84. PMC: 4127022. DOI: 10.1093/scan/nst097. View

10.

Santana I, Duro D, Lemos R, Costa V, Pereira M, Simoes M . [Mini-Mental State Examination: Screening and Diagnosis of Cognitive Decline, Using New Normative Data]. Acta Med Port. 2016; 29(4):240-8. DOI: 10.20344/amp.6889. View

11.

Strassman R . Human psychopharmacology of N,N-dimethyltryptamine. Behav Brain Res. 1996; 73(1-2):121-4. DOI: 10.1016/0166-4328(96)00081-2. View

12.

Sheehan D, Lecrubier Y, Sheehan K, Amorim P, Janavs J, Weiller E . The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1999; 59 Suppl 20:22-33;quiz 34-57. View

13.

Rolls E, Cheng W, Feng J . The orbitofrontal cortex: reward, emotion and depression. Brain Commun. 2020; 2(2):fcaa196. PMC: 7749795. DOI: 10.1093/braincomms/fcaa196. View

14.

Redcay E, Schilbach L . Using second-person neuroscience to elucidate the mechanisms of social interaction. Nat Rev Neurosci. 2019; 20(8):495-505. PMC: 6997943. DOI: 10.1038/s41583-019-0179-4. View

15.

Wada S, Honma M, Masaoka Y, Yoshida M, Koiwa N, Sugiyama H . Volume of the right supramarginal gyrus is associated with a maintenance of emotion recognition ability. PLoS One. 2021; 16(7):e0254623. PMC: 8297759. DOI: 10.1371/journal.pone.0254623. View

16.

Pallavicini C, Cavanna F, Zamberlan F, de la Fuente L, Ilksoy Y, Perl Y . Neural and subjective effects of inhaled N,N-dimethyltryptamine in natural settings. J Psychopharmacol. 2021; 35(4):406-420. DOI: 10.1177/0269881120981384. View

17.

Vogt S, Ley L, Erne L, Straumann I, Becker A, Klaiber A . Acute effects of intravenous DMT in a randomized placebo-controlled study in healthy participants. Transl Psychiatry. 2023; 13(1):172. PMC: 10206108. DOI: 10.1038/s41398-023-02477-4. View

18.

Han M, Jiang G, Luo H, Shao Y . Neurobiological Bases of Social Networks. Front Psychol. 2021; 12:626337. PMC: 8119875. DOI: 10.3389/fpsyg.2021.626337. View

19.

Lindner P, Flodin P, Larm P, Budhiraja M, Savic-Berglund I, Jokinen J . Amygdala-orbitofrontal structural and functional connectivity in females with anxiety disorders, with and without a history of conduct disorder. Sci Rep. 2018; 8(1):1101. PMC: 5773614. DOI: 10.1038/s41598-018-19569-7. View

20.

Calhoun V, Wager T, Krishnan A, Rosch K, Seymour K, Nebel M . The impact of T1 versus EPI spatial normalization templates for fMRI data analyses. Hum Brain Mapp. 2017; 38(11):5331-5342. PMC: 5565844. DOI: 10.1002/hbm.23737. View